Plus Therapeutics

Plus Therapeutics

Pharmaceuticals, 4200 Marathon BLVD, Austin, Texas, 78756, United States, 11-50 Employees

plustherapeutics.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: +12*********

Who is PLUS THERAPEUTICS

Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat...

Read More

map
  • 4200 Marathon BLVD, Austin, Texas, 78756, United States Headquarters: 4200 Marathon BLVD, Austin, Texas, 78756, United States
  • 2019 Date Founded: 2019
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 446110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PLUS THERAPEUTICS

Plus Therapeutics Org Chart and Mapping

Employees

Daniel Ortega

Director, Chemistry,Manufacturing, and Controls

Pius Maliakal

Vice President Clinical Ops

Omar Algunaid

Manager, Drug Development and Production

Oluwakemi Lawal

Senior Clinical Research Associate

Ryan Kompare

Process Development Engineer I

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Plus Therapeutics

Answer: Plus Therapeutics's headquarters are located at 4200 Marathon BLVD, Austin, Texas, 78756, United States

Answer: Plus Therapeutics's phone number is +12*********

Answer: Plus Therapeutics's official website is https://plustherapeutics.com

Answer: Plus Therapeutics's revenue is $5 Million to $10 Million

Answer: Plus Therapeutics's SIC: 2834

Answer: Plus Therapeutics's NAICS: 446110

Answer: Plus Therapeutics has 11-50 employees

Answer: Plus Therapeutics is in Pharmaceuticals

Answer: Plus Therapeutics contact info: Phone number: +12********* Website: https://plustherapeutics.com

Answer: Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate, Rhenium-186 Nanoliposome, is being evaluated in the NIH-supported multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access